The most comprehensive ecosystem in early stage investing.
Newable sources around 1,500 investment opportunities every year because of our reputation and the ecosystem programmes we run. Our team of analysts undertake a process of general commercial and financial analysis to create a long list of 400. Company meetings and product demonstrations then follow to arrive at around 70 investment case that are put before investors at regular Company Presentation Events.
With a particular focus on drug therapies, digital health and medical device technologies, Angels in MedCity brings potential investors together with life sciences experts in a programme aimed at both people who are new to investing and experienced investors who have little or no experience in the life sciences sector. Angels in MedCity is a partnership between MedCity, Newable Private Investing and Angels4LifeSciences.
This programme provides investors with inside access to early stage space related investment opportunities in 3 categories: Ecosystem (space application), Downstream (Software) and Upstream (Hardware. We partner with the most experienced and influential companies and government organisations in the industry including Seraphim, European Space Agency and the Satellite Applications Catapult.
The City of London Corporation has been the core supporter and the initial funding partner of the Angels in the City initiative since its launch in October 2011. The programme aims to increase the awareness of individuals to become investors and to bring their financial capacity and business experience to invest in innovative, entrepreneurs with high growth potential in the City fringes, including the exciting Tech City cluster.
Newable Private Investing is a syndicate partner of the Angel Co-Investment Fund (CoFund). The £100m Fund CoFund was launched in November 2011 with grants from the Regional Growth Fund and the British Business Bank. Newable was selected as one of original partners The London Co-Investment Fund (LCIF). This fund established by Funding London and Capital Enterprise has the aim of investing £23m in London-based, seed stage companies in the Science, Digital and Technology sectors.